We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Alimera Sciences Inc | NASDAQ:ALIM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.18 | -4.80% | 3.57 | 2.75 | 45.00 | 3.84 | 3.54 | 3.60 | 57,870 | 01:00:00 |
Delaware
|
|
001-34703
|
|
20-0028718
|
||
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
||
|
|
|
||||
6120 Windward Parkway
Suite 290
Alpharetta, Georgia
|
|
30005
|
||||
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Not Applicable
|
(Former name or former address if changed since last report.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value per share
|
ALIM
|
The Nasdaq Stock Market LLC
(Nasdaq Global Market)
|
Proposal 1:
|
To authorize the Company’s board of directors (the “Board”), in its sole and absolute discretion, and without further action of the stockholders, to file an amendment to the Company’s restated certificate of incorporation (the “Certificate of Incorporation”), to effect a reverse stock split of the Company’s issued and outstanding Common Stock, par value $0.01 per share (“common stock”), at a ratio to be determined by the Board, ranging from one-for-five to one-for-30 (the “Reverse Split”), with the Reverse Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion, but no later than May 4, 2020, when the authority granted in the proposal to implement the Reverse Split would terminate.
|
|
|
Proposal 2:
|
To approve an adjournment of the Special Meeting, if necessary and appropriate, as determined by the Board in its sole discretion, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve Proposal 1 or to constitute a quorum.
|
Proposal 1:
|
Reverse Split.
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
57,727,306
|
4,119,056
|
38,312
|
0
|
Proposal 2:
|
Adjournment.
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
58,360,626
|
3,470,041
|
54,007
|
0
|
|
ALIMERA SCIENCES, INC.
|
|
|
|
|
Dated: November 7, 2019
|
By:
|
/s/ J. Philip Jones
|
|
Name:
|
J. Philip Jones
|
|
Title:
|
Chief Financial Officer
|
1 Year Alimera Sciences Chart |
1 Month Alimera Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions